According to ImmunoGen 's latest financial reports the company's total assets are A$1.30 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | A$0.51 B | -29.3% |
2021-12-31 | A$0.72 B | 57.05% |
2020-12-31 | A$0.46 B | 37.42% |
2019-12-31 | A$0.33 B | -19.86% |
2018-12-31 | A$0.41 B | 11.09% |
2017-12-31 | A$0.37 B | |
2016-06-30 | A$0.37 B | -6.95% |
2015-06-30 | A$0.40 B | 128.85% |
2014-06-30 | A$0.17 B | -24.88% |
2013-06-30 | A$0.23 B | 32.75% |
2012-06-30 | A$0.17 B | -13.51% |
2011-06-30 | A$0.20 B | 24.81% |
2010-06-30 | A$0.16 B | 30.56% |
2009-06-30 | A$0.12 B | 43.6% |
2008-06-30 | A$86.98 M | -8.41% |
2007-06-30 | A$94.97 M | -25.05% |
2006-06-30 | A$0.12 B | -12.2% |
2005-06-30 | A$0.14 B | -18.71% |
2004-06-30 | A$0.17 B | 0.47% |
2003-06-30 | A$0.17 B | -34.8% |
2002-06-30 | A$0.27 B | -12.85% |
2001-06-30 | A$0.31 B |